Concepedia

Tomomi Date

TD

3

Publications

257

Citations

3

H-Index

2001

Active since

Affiliations

Nagoya Medical Center(Current)

Tomomi Date is an author at Nagoya Medical Center specializing in toxicology, medicine, and pharmacology.

Top concepts

Publications per year

2001–2017

3

Publications

3

A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations

Takeshi Yamaura, Toshiyuki Nakatani, Ken Uda et al. · Blood · 2017 · 143 citations

Ceramide kinase deficiency improves diet‐induced obesity and insulin resistance

Susumu Mitsutake, Tomomi Date, Hazuki Yokota et al. · FEBS Letters · 2012 · 62 citations · Full text

Cytotoxicity of the Hinokitiol-Related Compounds, .GAMMA.-Thujaplicin and .BETA.-Dolabrin.

Eiko Matsumura, Yasuhiro Morita, Tomomi Date et al. · Biological and Pharmaceutical Bulletin · 2001 · 52 citations

, , +12

Rows per page

1–3 of 3